about
Surgical treatment of fibroids for subfertilityRecurrent miscarriageQuantitative serial MRI of the treated fibroid uterusGaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocolCB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancyCombination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series.A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometriumEctopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast.The peritoneum is both a source and target of TGF-β in women with endometriosis.Cotinine exposure increases Fallopian tube PROKR1 expression via nicotinic AChRalpha-7: a potential mechanism explaining the link between smoking and tubal ectopic pregnancyThe burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres.The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy.Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancyEvidence of prokineticin dysregulation in fallopian tube from women with ectopic pregnancy.Economic evaluation of diagnosing and excluding ectopic pregnancyEvaluation of ADAM-12 as a diagnostic biomarker of ectopic pregnancy in women with a pregnancy of unknown location.Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis.Elevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis.Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery?Estrogen receptor (ER) agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3.Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancyPlacental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy.Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study.The impact of tubal ectopic pregnancy in Papua New Guinea--a retrospective case review.Adhesion molecules and the normal endometrium.Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practiceShotgun proteomics identifies serum fibronectin as a candidate diagnostic biomarker for inclusion in future multiplex tests for ectopic pregnancyThe association between smoking and ectopic pregnancy: why nicotine is BAD for your fallopian tube.Laboratory models for studying ectopic pregnancyNormally rising hCG does not predict live birth in women presenting with pain and bleeding in early pregnancy.Immunity and vaccines against sexually transmitted Chlamydia trachomatis infectionWnt activation downregulates olfactomedin-1 in Fallopian tubal epithelial cells: a microenvironment predisposed to tubal ectopic pregnancy.The paracrinology of tubal ectopic pregnancyHuman fallopian tube epithelium constitutively expresses integrin endometrial receptivity markers: no evidence for a tubal implantation window.Public awareness of human papillomavirus.The effect of uterine fibroids on embryo implantation.Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities.Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection.ESHRE guideline: management of women with endometriosis.
P50
Q24203015-32DC3790-8830-4BFB-8DFB-9D40EC0E8698Q28176124-13A8C571-DF4B-43F6-B844-C56FEDF7ACAEQ28540610-B6D51E3F-F87E-47A2-B568-B829A333F318Q30515721-355962AA-B791-4995-B8C6-CAADC5E532BFQ33394242-4A0A694D-BDF5-4394-8ED1-017F0FD691C2Q33762029-68A8F3EE-6999-4D42-BE52-9612008309E3Q33826595-3A960FAD-CD3B-4CAB-B865-25BFA0D99215Q33999854-277293CB-0DDD-41C4-B762-7700774627FBQ34160182-C14D0F63-B96D-4A61-9DD7-CCE0A23F9F04Q34254540-AE78DBB2-27A7-43D8-9FE8-62345B29F976Q34261808-FBDF5D39-A9A0-4496-A11B-E51C4FA0E864Q34270873-E29C1DE3-2CD8-4E1B-A558-DDFDA0385A78Q34341068-B84FCACC-366A-4400-A635-AA105C0AA3AFQ34343543-D9736EB4-4E3D-4447-80C4-4CD839436FA8Q34343560-F62AE235-78E5-4C30-8133-F0CFB5BD27E6Q34395372-E16A9D78-712F-487E-A3C6-D0A85D2BA310Q34396502-49D23AEA-4A5C-45DB-B938-A3001117B119Q34396510-F8FF3548-D521-4353-8C5B-C2981396836EQ34416727-80FC8B97-5473-4567-8A5B-676F2F44F74CQ34430294-43ED2163-5B61-4B4F-A4A7-6D5B22A663CDQ34469192-139F054D-008B-4381-B641-6C0239B6596EQ34473698-81DD02FC-8F5B-45B9-81E9-8FC40C37ABDCQ34569880-529309F6-FE01-4E8B-A0EC-F5AE532AF2DEQ34655270-CFB447F5-64A4-4559-9F12-2AC0C07F79B7Q34740205-B8FD8883-10C0-4382-86B5-9B0610BD70A1Q34754603-5C8277B4-2243-4FE4-B4B9-F3D7ADAC27D7Q34796295-CAF536AA-9B6E-40A9-A6D0-A00032D4E0D3Q35107231-F34A3811-365F-4F32-8983-D240073D17B0Q35532600-F6421373-A930-49F3-8DB8-03A042B4C9BDQ35534753-7E7BC8C4-E28A-4F6D-B029-D5957D2F50ADQ35536190-43676A2E-7E33-4D25-8935-B5A0862E224AQ35738031-84DD5954-6859-4D3D-B853-ED305B0559A1Q35748999-F5220EAE-5EC1-41DC-9C36-18C4D1B86726Q35797374-0AC224FF-15B1-430A-984E-558D043B8DBBQ36705407-09DFCA0C-ED9A-4A87-8A43-10B8B4B79146Q36981323-09D28612-F5CA-4268-95C3-9D98CFDA0886Q37029975-DEDF51E1-F353-45FC-BA23-61EFAFB01180Q37423559-3AA00249-4A1F-494B-910F-31F51AA296E5Q37855924-51343BE3-C4E7-40E4-AB26-788CC14E5A0BQ38179305-06087D7A-5C7A-434E-8082-49BCA845649A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew W Horne
@ast
Andrew W Horne
@en
Andrew W Horne
@es
Andrew W Horne
@nl
Andrew W Horne
@sl
type
label
Andrew W Horne
@ast
Andrew W Horne
@en
Andrew W Horne
@es
Andrew W Horne
@nl
Andrew W Horne
@sl
altLabel
Andrew Horne
@en
prefLabel
Andrew W Horne
@ast
Andrew W Horne
@en
Andrew W Horne
@es
Andrew W Horne
@nl
Andrew W Horne
@sl
P106
P21
P31
P496
0000-0002-9656-493X